Dr. N. Leigh Anderson Ph.D. serves as Independent Director of the Company. N. Leigh Anderson has served as a member of our board of directors since May 2017. Dr. Anderson has served as Chief Executive Officer of SISCAPA Assay Technologies, a developer of diagnostic testing technology, of which he was a co-founder, since 2011, and has served as the Chief Executive Officer of the Plasma Proteome Institute, a non-profit biomedical scientific research institute in Washington, D.C., of which he is also a founder, since 2002. From 2001 to 2002, Dr. Anderson served as the Chief Scientific Officer and a member of the board of directors of Large Scale Biology Corporation, a public biotechnology company. Dr. Anderson also served as a member of the board of directors and a member of the audit committee of Dade Behring Holdings, Inc., a publicly held medical diagnostics equipment manufacturer, from 2002 until its acquisition by Siemens AG in 2007. Dr. Anderson earned a B.A. degree in physics from Yale University and a Ph.D. in molecular biology from Cambridge University.
As the Independent Director of Luna Innovations Inc, the total compensation of N Anderson at Luna Innovations Inc is $63,250. There are 7 executives at Luna Innovations Inc getting paid more, with Scott Graeff having the highest compensation of $961,123.
N Anderson is 70, he's been the Independent Director of Luna Innovations Inc since 2017. There are 1 older and 8 younger executives at Luna Innovations Inc. The oldest executive at Luna Innovations Inc is Warren Phelps, 73, who is the Independent Director.
N's mailing address filed with the SEC is C/O LUNA INNOVATIONS INCORPORATED, 301 1ST STREET SW, SUITE 200, ROANOKE, VA, 24011.
Over the last 18 years, insiders at Luna Innovations Inc have traded over $12,047,035 worth of Luna Innovations Inc stock and bought 167,773 units worth $204,903 . The most active insiders traders include Clinic Carilion, Kent A Murphy, eRichard Roedel. On average, Luna Innovations Inc executives and independent directors trade stock every 88 days with the average trade being worth of $203,723. The most recent stock trade was executed by Brian Soller on 4 April 2024, trading 100,000 units of LUNA stock currently worth $149,000.
who we are: we are scientists, engineers, and business professionals; developing and manufacturing a new generation of technologies and products for the aerospace, automotive, energy, defense, healthcare, and telecommunications industries. as a result of our merger with advanced photonix, inc. we also package optoelectronic semiconductors into high-speed optical receivers (hsor), customize optoelectronic subsystems, and offer terahertz instrumentation. additionally, we provide applied research services for companies and government-funded projects in areas of sensing, advanced materials, and health sciences. why it matters: our business model is designed to accelerate the process of bringing new and innovative products to market. how we’re structured: we are organized into two main business segments, our products and licensing segment and our technology development segment. our products and licensing segment develops, manufactures and commercializes products to serve our markets’ needs;
Luna Innovations Inc executives and other stock owners filed with the SEC include: